Skip to main content
2026 AANS Annual Scientific Meeting Main banner

    Tumor

    Tumor Rapid Fire Abstracts

    Sunday, May 3, 2026
    4:00 PM - 5:30 PM CT
    Location:Stars at Night Ballroom 2-3, Level 3, Stage 1, HBGCC

    Presentations:

    • 4:00 PM - 4:02 PM CT
      Predictors of Biopsy in Glioblastoma: A SEER-Based Epidemiologic Study

      Presenting Author: Alyssa M. Persano, BS – Tufts University School of Medicine

    • 4:03 PM - 4:05 PM CT
      Intracranial Tumors Elicit Systemic Sympathetic Hyperactivity That Limits Immunotherapeutic Responses

      Presenting Author: Peter Fecci, MD PhD – University of Colorado Anschutz

    • 4:03 PM - 4:05 PM CT
      Wave Events in Neoplastic Meningitis: A Common Phenomenon Cured with Ventriculoperitoneal Shunting (Rosenblum-Mahaley Clinical Research Award)

      Presenting Author: Aarav Badani, n/a – Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA

    • 4:06 PM - 4:08 PM CT
      Are All Bilsky 3 Lesions the Same? Redefining High-Grade Epidural Spinal Cord Compression with a Novel Classification System

      Presenting Author: Harsh Jain, MBBS – Vanderbilt University Medical Center

    • 4:09 PM - 4:11 PM CT
      Modeling Tumor-Induced Sarcopenia and Ambulatory Dysfunction in Spinal Metastases

      Presenting Author: Ramzy Ahmed, B.S. – Eastern Virginia Medical School

    • 4:12 PM - 4:14 PM CT
      Patterns of Care and Outcomes of Stereotactic Radiosurgery for Radiation-Induced Meningiomas: A Single-Institution Cohort Analysis (Lunsford & Leksell Radiosurgery Award)

      Presenting Author: Saachi Jhandi, MS – Spencer Fox Eccles School of Medicine at the University of Utah

    • 4:15 PM - 4:17 PM CT
      Multi-omic Analysis Predicts Response to Laser Interstitial Thermal Therapy

      Presenting Author: Jay Chandar, MD – Department of Neurological Surgery, University of Miami

    • 4:18 PM - 4:20 PM CT
      Establishing the Utility of Deep Learning for H&E-Based Meningioma Molecular Classification and Outcome Prediction

      Presenting Author: Alexander Landry, MD – University of Toronto

    • 4:21 PM - 4:23 PM CT
      Exportin-1 Inhibition with Selinexor Enhances Temozolomide Efficacy in Meningioma Cells

      Presenting Author: timuçin avsar, PhD – Bahcesehir University

    • 4:24 PM - 4:26 PM CT
      Extracellular Vesicle–Based Drug Delivery as a Potential Therapeutic Strategy Against Gliomas

      Presenting Author: Prishita Banerji, M.D – University of Niš Faculty of Medicine

    • 4:27 PM - 4:29 PM CT
      Postoperative Infection in Patients with Glioblastoma and Type 2 Diabetes Mellitus

      Presenting Author: Tara Elizabeth Dalton, MD – Duke University School of Medicine

    • 4:30 PM - 4:32 PM CT
      Single Cell Sequencing Identifies Sox2+ Folliculostellate Cells as Master Orchestrators of Tumor Microenvironment Signaling in SF-1 Lineage PitNETs

      Presenting Author: Michelle A. Wedemeyer, MD, PhD – Nationwide Childrens Hospital and The Ohio State College of Medicine

    • 4:33 PM - 4:35 PM CT
      Stromal Cell-Driven Immunosuppression as a Novel Target in Glioma Therapy

      Presenting Author: Brandon H. Bergsneider, MS – Stanford University School of Medicine

    • 4:39 PM - 4:41 PM CT
      A Prospective Study of Inflammatory Mediators in Cerebrospinal Fluid After Intraoperative Radiotherapy of Brain Tumors

      Presenting Author: Ehab Shiban, MD, Prof. , MHBA, M.Sc. – Medical University Lausitz

    • 4:42 PM - 4:44 PM CT
      Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation

      Presenting Author: Hailiang Tang, MD, PHD – Huashan Hospital, Fudan University

    • 4:48 PM - 4:50 PM CT
      Intraoperatively Differentiation of Brain Tumors by Optical Spectroscopy Measurements

      Presenting Author: Fernando S. Chiwo, PhD – The University of Texas Medical Branch

    • 4:51 PM - 4:53 PM CT
      Leveraging Non-Linear Color Space Transformations To Enhance Categorization of Glioblastoma Cell Density at Experimental Margin by 5-ALA induced Protoporphyrin IX Fluorescence

      Presenting Author: Jhair Colan, BS – University of Pittsburgh School of Medicine

    • 4:54 PM - 4:56 PM CT
      Nanocarrier-Mediated Intra-Arterial Delivery Strategies for Blood–Brain Barrier Modulation in Glioblastoma: A Technical Note

      Presenting Author: Jeremiah H. Wijaya, MD, MPH, FRSPH – Monash University

    • 4:57 PM - 4:59 PM CT
      Spatial Transcriptomic Analysis Reveals Primary Cancer-Specific Gene Expression Patterns in Brain Metastases

      Presenting Author: Anthony G. Chesebro, PhD – Stony Brook University

    • 5:00 PM - 5:02 PM CT
      Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma: A multi-institutional study

      Presenting Author: Trenton Kite, BS – Allegheny Health Network

    • 5:03 PM - 5:05 PM CT
      Tumor-Infiltrating Lymphocyte Therapy from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy

      Presenting Author: Bryan Choi, MD

    • 5:06 PM - 5:08 PM CT
      Brain Metastasis Prediction from Lung Adenocarcinoma Tissue and Detection with Liquid Biopsy

      Presenting Author: Jeffrey A. Zuccato, MD, PhD – University of Oklahoma Health Sciences Center

    • 5:12 PM - 5:14 PM CT
      Comprehensive Ex Vivo Drug Sensitivity Mapping Across 666 Clinical Glioblastoma Samples Identified Distinct Response Networks Linked To Patient Survival

      Presenting Author: Hsien-Chung Chen, MD – Department of Neurosurgery, The Warren Alpert Medical School of Brown University

    • 5:15 PM - 5:17 PM CT
      Developing Novel Meningioma Patient-derived Organotypic Tumor Spheroids and Xenograft Models to Evaluate Efficacy of Mesothelin CAR T-cells and Synergy with Radiation Therapy

      Presenting Author: Rishab Ramapriyan, MD – Resident

    • 5:18 PM - 5:20 PM CT
      Electrocorticographic Detection of Speech Networks in Glioma-infiltrated Cortex

      Presenting Author: Vardhaan S. Ambati, M.S. – UCSF Department of Neurological Surgery

    • 5:27 PM - 5:29 PM CT
      Neuron-Glioma Interactions Driven by (R)-2-hydroxyglutarate Promote Growth at the Infiltrative Margin of IDH-Mutant Gliomas

      Presenting Author: Brian Hsueh, MD, PhD – Massachusetts General Hospital